Related Experiment Video
Updated: Jul 14, 2026

Testing the Role of Multicopy Plasmids in the Evolution of Antibiotic Resistance
Published on: May 2, 2018
Evolutionary dynamics of the multidrug-resistant Salmonella Infantis harbouring the pESI megaplasmid across Europe
Patricia Alba1, Elena Lavinia Diaconu1, Virginia Carfora1
1Department of General Diagnostics, National Reference Laboratory for Antimicrobial Resistance, Istituto Zooprofilattico Sperimentale del Lazio e della Toscana "M. Aleandri", Rome, Italy.
Abstract:
Multidrug-resistant Salmonella enterica subsp. enterica serovar Infantis clone, harbouring the pESI megaplasmid, first described in Israel in 2014, is consistently reported in poultry and humans worldwide. This study aimed to investigate the genomic epidemiology of S. Infantis collected by nine European Public Health Institutions from samples of different origins (human, food and animal sources) and understand the evolutionary dynamics of pESI-like in Europe. The resolved pESI-like sequences have also been compared with complete publicly available pESI-like sequences from other countries, in a One Health context. The circulation of a S. Infantis clone in Europe carrying the mosaic megaplasmid pESI-like has been associated with resistance to sulphonamides (sul), tetracycline (tet), streptomycin and spectinomycin (aadA1). In recent years, bla CTX-M-1-positive pESI-like plasmids have been increasingly detected in the extended-spectrum beta-lactamase-producing S. Infantis clone. Using a combined short- and long-read sequencing approach, two main types of pESI variants have been identified, differing in the accessory gene content, including the bla CTX-M variant, indicating a certain stability of pESI variants detected in different geographical regions and sources over time (2011-2021). Moreover, the differences were related to the acquisition of resistance, virulence or fitness-enhancing genes that would potentially benefit the Salmonella host.
Insights
A multidrug-resistant Salmonella Infantis clone carrying the pESI megaplasmid circulates globally. This study reveals two main pESI variants in Europe, differing in accessory genes and conferring antimicrobial resistance, impacting One Health surveillance.
Area of Science:
- Microbiology
- Genomics
- Epidemiology
Background:
- Multidrug-resistant *Salmonella enterica* subsp. *enterica* serovar Infantis* (S. Infantis) clone, associated with the pESI megaplasmid, emerged in Israel in 2014 and is now a global concern in poultry and humans.
- This clone exhibits resistance to multiple antibiotics, including sulphonamides, tetracycline, streptomycin, and spectinomycin, with increasing detection of extended-spectrum beta-lactamase (ESBL) genes like *bla*CTX-M-1.
Purpose of the Study:
- To investigate the genomic epidemiology of *S. Infantis* in Europe, analyzing samples from human, food, and animal sources.
- To understand the evolutionary dynamics of pESI-like plasmids within Europe and compare them globally in a One Health context.
Main Methods:
- Utilized a combination of short- and long-read sequencing approaches for comprehensive genomic analysis.
- Collected and analyzed *S. Infantis* samples from nine European Public Health Institutions between 2011 and 2021.
- Compared European pESI-like sequences with publicly available global sequences.
Main Results:
- Identified the circulation of a *S. Infantis* clone in Europe carrying a mosaic pESI-like megaplasmid, associated with specific antimicrobial resistance genes (*sul*, *tet*, *aadA1*).
- Detected two main types of pESI variants in Europe, differing in accessory gene content, including *bla*CTX-M variants, indicating stability across different regions and sources over a decade (2011-2021).
- Observed that variations in pESI variants are linked to the acquisition of resistance, virulence, or fitness-enhancing genes.
Conclusions:
- The study confirms the sustained circulation of a specific multidrug-resistant *S. Infantis* clone and its pESI-like megaplasmid variants in Europe.
- The genomic diversity of pESI variants suggests ongoing evolution and adaptation, potentially conferring advantages to the *Salmonella* host.
- Findings underscore the importance of integrated genomic surveillance across human, animal, and food sources for effective One Health antimicrobial resistance monitoring.
Related Concept Videos
Evolution of Microbial Genome
Mechanism of Antibiotic Resistance in MRSA
Plasmids
Evolution of New Traits in Microbes
Clinical Significance of Antibiotic Resistance
Development of Antibiotic Resistance

